101 studies found for:    Open Studies | "Lacrimal Apparatus Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa
Conditions: Corneal Disease;   Blepharitis;   Lacrimal Apparatus Diseases
Interventions: Device: Handheld IVCM Vivascope 3000 (Caliber/Mavig) anesthesic eyedrop : oxybuprocaïne Thea 1,6 mg/0,4 ml;   Device: Multifluorescence IVCM vivascope 1500 ML (Caliber/Mavig);   Procedure: microangiography
2 Unknown  Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
Condition: Dry Eye Syndromes
Interventions: Drug: euphrasia based homeopathic therapy and cyclosporin;   Drug: cyclosporin solution
3 Recruiting Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients
Conditions: Epiphora;   Conjunctivitis
Interventions: Device: Perforated Punctal plugs;   Procedure: Crawford tube insertion;   Device: Crawford lacrimal tube
4 Not yet recruiting A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye
Condition: Dry Eye Syndromes
Interventions: Drug: Omega 3;   Drug: Optive Advanced;   Drug: Optive
5 Recruiting Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Drug: SS-1;   Drug: Placebo
6 Recruiting Interest of Eye Movement Measurements in the Comprehension of Dry Eyes Symptoms
Conditions: Dry Eye Syndromes;   Blinking
Intervention: Device: Infrared oculography
7 Recruiting Risk and Importance of Peroperative Nasal Hemorrhage in the Treatment of Lacrimal Duct Obstruction in Young Children
Condition: Lacrimal Duct Obstruction
Intervention: Procedure: "pushed" mono-canaliculonasal intubation
8 Not yet recruiting Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: BMS-931699;   Drug: BMS-986142;   Drug: Placebo
9 Recruiting Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Condition: Dry Eye Disease
Interventions: Drug: P-321 Ophthalmic Solution;   Drug: P-321 Ophthalmic Solution placebo
10 Not yet recruiting Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
Condition: Tear Deficient Dry Eye Disease.
Interventions: Drug: P-321 Ophthalmic Solution;   Drug: P-321 Ophthalmic Solution placebo
11 Recruiting Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: KPI-121 0.25% Ophthalmic Suspension;   Drug: Vehicle of KPI-121 0.25% Ophthalmic Suspension
12 Not yet recruiting Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Condition: Dry Eye Syndromes
Interventions: Drug: AGN-195263;   Drug: Vehicle
13 Recruiting Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease
Conditions: Dry Eye Syndromes;   Keratoconjunctivitis Sicca
Interventions: Drug: KPI-121 0.25% Ophthalmic Suspension;   Drug: Vehicle of KPI-121 0.25% Ophthalmic Suspension
14 Recruiting Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
Conditions: Dry Eye Syndrome;   Keratoconjunctivitis Sicca
Intervention: Device: Oculeve Intranasal Neurostimulator
15 Not yet recruiting Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With Pterygium
Conditions: Dry Eye Syndromes;   Pterygium
Interventions: Drug: Dipyridamole;   Drug: Placebo
16 Not yet recruiting A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases
Condition: Dermatomyositis, Polymyositis, Sjogren's, SLE, SSc
Interventions: Biological: MEDI7734;   Biological: Placebo
17 Recruiting Study to Evaluate the Efficacy and Safety of CKD-350
Condition: Dry Eye Syndrome
Interventions: Drug: Xenobella;   Drug: Isotonic 0.3% Sodium Hyaluronate
18 Recruiting Clinical Outcomes Following Treatment With SYSTANE® BALANCE
Condition: Dry Eye
Interventions: Other: Propylene glycol, 0.6% eye drops;   Other: Lubricant eye drops;   Other: Preservative-free 0.9% saline solution
19 Not yet recruiting Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: CDZ173;   Drug: Placebo
20 Not yet recruiting Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye Syndrome
Condition: Dry Eye Syndrome
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years